Pharmacological evidence of medicinal cannabis in oncology: a systematic review

@article{Brown2019PharmacologicalEO,
  title={Pharmacological evidence of medicinal cannabis in oncology: a systematic review},
  author={Danielle Brown and Michael Watson and Janet Schloss},
  journal={Supportive Care in Cancer},
  year={2019},
  pages={1-13}
}
PurposeThis systematic literature review examines research into the use of medicinal cannabis in cancer management. The aim was to identify the gaps in knowledge on the dose, dosing schedule and absorption of the administration routes of medicinal cannabis use in oncology.MethodsA comprehensive search of the literature was conducted across six databases to identify original data reporting the pharmacology of medicinal cannabis in oncology.ResultsEighteen articles were selected for review. Of… 
Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: A systematic review.
TLDR
Evidence from RCTs that medicinal cannabis increases appetite in people with cancer is limited and future research should carefully consider biological mechanisms to guide more nuanced selection of endpoints and interventions, including product, dose and administration.
Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review
TLDR
It is indicated that medical cannabis is mostly used for three approved indications: to manage refractory nausea and vomiting, to complement pain management, and to improve appetite and food intake.
Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors
TLDR
A practical and helpful guide for prescribing doctors is provided, including suggested posology, titration strategies and cannabinoid amounts in herbal preparations obtained from different sources of medical cannabis.
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019
TLDR
The body of evidence for medical cannabis requires more rigorous evaluation before consideration as a treatment option for many conditions, and evidence necessary to inform policy and treatment guidelines is currently insufficient for many condition.
The Highs and Lows of Cannabis in Cancer Treatment and Bone Marrow Transplantation
TLDR
The possible contradiction between the direct anti-tumor and the immune-modulatory effects of cannabinoids is addressed and better understanding of the mechanism of cannabinoids influence is essential to design therapies that will allow cannabinoids to be incorporated into the clinic.
Therapeutic potential of cannabinoids in combination cancer therapy.
Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series
TLDR
This case series suggests that topical cannabinoids may be helpful for patients with chemotherapy-induced peripheral neuropathy who used topical creams containing the cannabinoids delta-nine-tetrahydrocannabinol (THC) and/or cannabidiol (CBD).
Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview
TLDR
This mini‐review focuses on the medicinal importance of the plant and its legal status worldwide; the pharmacological compounds and its therapeutic potential along with the underlying public health concerns and future perspective are discussed.
Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences
TLDR
The purpose of this study was to review cannabis use during pregnancy and breastfeeding including epidemiological aspects, therapeutic or preventive strategies, and experimental considerations and results from animal models of perinatal cannabis exposure to analyze the underlying neurobiological mechanisms and to identify new therapeutic approaches.
Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back
TLDR
The roles of the endocannabinoid system in immunity and the emerging data about the effects of cannabinoids on the immune response in different pathologies are discussed and the complexities of using cannabinoid-based treatments in each of these conditions are discussed.
...
...

References

SHOWING 1-10 OF 72 REFERENCES
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications.
TLDR
Favorable outcomes are demonstrated for chemotherapy-induced nausea and vomiting and cancer-related pain, with evidence of advantageous neurological interactions and short- and long-term side effects appear to be manageable and to subside after discontinuation of the drug.
Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel.
TLDR
Coadministration of medicinal cannabis, as herbal tea, in cancer patients treated with irinotecan or docetaxel does not significantly influence the plasma pharmacokinetic parameters with and without concomitant medicinal cannabis.
Cannabis : A Prehistoric Remedy for the Deficits of Existing and Emerging Anticancer Therapies
TLDR
This review summarizes the historical perspective of C. sativa, its potential mechanism of action, and pharmacokinetic and pharmacodynamic aspects of cannabinoids, with special emphasis on their anticancer potentials.
The Medicinal Use of Cannabis and Cannabinoids—An International Cross-Sectional Survey on Administration Forms
TLDR
The survey was completed by 953 participants from 31 countries, making this the largest international survey on a wide variety of users of cannabinoid-based medicine performed so far, and in general, herbal non-pharmaceutical CBMs received higher appreciation scores by participants than pharmaceutical products containing cannabinoids.
A Survey of the Way Pharmacokinetics are Reported in Published Phase I Clinical Trials, with an Emphasis on Oncology
TLDR
Pharmacokinetic findings should be integrated into the broader perspective of drug development, through the study of their relationship with toxicity and/or efficacy, even in the early phase I stages, it is found.
A Review of the Therapeutic Antitumor Potential of Cannabinoids.
TLDR
A large number of cannabinoid compounds have been discovered, developed, and used to study the effects of cannabinoids on cancers in model systems, but few clinical trials have been conducted on the use of cannabinoids in the treatment of cancers in humans.
The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD
Dr. Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Medical Director of PHYTECS, a biotechnology company researching and developing innovative approaches
Chemistry, Metabolism, and Toxicology of Cannabis: Clinical Implications
TLDR
An attempt has been made to summarize the properties of cannabis and its derivatives, and to discuss the implications of its use with emphasis on bioavailability, limit of detection, carry over period and passive inhalation, important factors for detection and diagnosis.
...
...